ACURA PHARMACEUTICALS, INC — key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2021)

$1.6M

Net Income/Loss (FY2021)

-$879.0K

Total Assets (FY2021)

$860.0K

Total Equity (FY2021)

$178.0K

Cash Flows from Operating Activities (FY2021)

-$742.0K

Source: ACURA PHARMACEUTICALS, INC 10-K filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.